Abstract: Background: There are several treatment options, ranging from conservative therapy to surgical release, for trigger finger, a prevalent condition in rheumatologic practice that results in a triggering or locking that may provide an uncomfortable sensation. The study's goal was to examine the functional results of percutaneous A1 pulley release and corticosteroid injection administration in the treatment of trigger finger patients.
Methods: This is a prospective study of 30 patients with Trigger Finger conducted between May 2021 to May 2022 with a follow up of 2 years
Results: There were 12 female and 18 male participants in our study, and the right side was the side that was most frequently afflicted. The patient was between the ages of 29 and 59, with a mean of 43. All patients who underwent percutaneous trigger finger release were able to flex and extend their fingers without any pain at the end of six months, returning them to their pre-injury state. The average VAS score after injection was 3. The Quinnel score 4 drastically decreased from a post- injection mean of 3.The average VAS score after surgery was 2. After surgery, the Quinnel score 3 drastically decreased from a mean of 1. Every patient was pleased with the procedure and the functional outcomes.
Conclusion: When compared to intraarticular steroid injection, percutaneous trigger finger release is a viable choice for treating trigger finger.
